A Study of MBS314 in Participants With Relapsed/Refractory Multiple Myeloma.

NCT06232096 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

154

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsed or Refractory Multiple Myeloma

Interventions

DRUG: MBS314 Injection

Sponsor

Beijing Mabworks Biotech Co., Ltd.